A questionnaire was developed and mailed in March 1999 to 270 adult kidney transplant recipients ... patient's source of funding for immunosuppressive medications, such as prednisone and ...
Sodium glucose co-transporter 2 inhibitors (SGLT2i) for pediatric kidney disease: the future is near
SGLT2 inhibitors were developed to block the co-transport of sodium and glucose in the renal tubule to increase renal glucose excretion as a treatment for diabetes. In adults, SGLT2 inhibitors improve ...
The drug is naturally eliminated from the body, so it is unlikely to accumulate or create new problems for people with kidney disease who are exposed to very small doses of this medication.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback